- Home
- RPRX vs WTRG Comparison
RPRX vs WTRG Comparison
Compare RPRX & WTRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- WTRG
- Stock Information
- Founded
- RPRX 1996
- WTRG 1901
- Country
- RPRX United States
- WTRG United States
- Employees
- RPRX N/A
- WTRG N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- WTRG Water Supply
- Sector
- RPRX Health Care
- WTRG Utilities
- Exchange
- RPRX Nasdaq
- WTRG Nasdaq
- Market Cap
- RPRX 14.2B
- WTRG 11.6B
- IPO Year
- RPRX 2020
- WTRG N/A
- Fundamental
- Price
- RPRX $34.02
- WTRG $38.87
- Analyst Decision
- RPRX Strong Buy
- WTRG Strong Buy
- Analyst Count
- RPRX 4
- WTRG 6
- Target Price
- RPRX $42.50
- WTRG $43.50
- AVG Volume (30 Days)
- RPRX 3.9M
- WTRG 1.5M
- Earning Date
- RPRX 05-08-2025
- WTRG 05-12-2025
- Dividend Yield
- RPRX 2.59%
- WTRG 3.35%
- EPS Growth
- RPRX 37.60
- WTRG 5.24
- EPS
- RPRX 2.45
- WTRG 2.23
- Revenue
- RPRX $2,263,845,000.00
- WTRG $2,257,670,000.00
- Revenue This Year
- RPRX $31.16
- WTRG $14.33
- Revenue Next Year
- RPRX $5.86
- WTRG $6.96
- P/E Ratio
- RPRX $13.85
- WTRG $17.39
- Revenue Growth
- RPRX 1.13
- WTRG 16.41
- 52 Week Low
- RPRX $24.05
- WTRG $33.18
- 52 Week High
- RPRX $34.20
- WTRG $41.78
- Technical
- Relative Strength Index (RSI)
- RPRX 61.77
- WTRG 45.78
- Support Level
- RPRX $32.18
- WTRG $36.40
- Resistance Level
- RPRX $34.11
- WTRG $41.19
- Average True Range (ATR)
- RPRX 0.82
- WTRG 0.96
- MACD
- RPRX 0.09
- WTRG -0.37
- Stochastic Oscillator
- RPRX 91.93
- WTRG 47.50
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About WTRG Essential Utilities Inc.
Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024.